Supplementary Figure 2 from A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma
Year: 2023
Type: supplementary-materials
Abstract: Data from an individual patient showing CD8 immune response to both native and heteroclitic peptides.
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361920792